Beijing TongRenTang Co., Ltd.SSE: 600085

Correction Announcement on Report for Q1 2026

May 1, 2026 · Issued by Beijing TongRenTang Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · May 1, 2026

On 6ix: 6ix.com/news/correction-announcement-on-report-for-q1-2026

Correction Announcement on Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Beijing TongRenTang Co., Ltd. on 6ix

Earlier from Beijing TongRenTang

Report for Q1 2026Apr 30
Announcement on Holding Subsidiary Obtaining Registration Certificate for Chinese Patent Medicines in MacaoApr 21
Announcement on Adjustment of Senior Management MembersApr 8
2025 Annual ReportMar 31
Announcement on Obtaining Product License from CanadaMar 5

Later from Beijing TongRenTang

Announcement on Holding Sub-subsidiary TONG REN TANG Chinese Medicine Obtaining the Hong Kong Proprietary Chinese Medicine Registration CertificateMay 27
Announcement on Obtaining Canadian Overseas Production Site Certification and Product Marketing ApprovalJun 6
Announcement on Resolutions of the 2025 Annual General MeetingJun 17
Announcement on Implementation of Dividend Distribution for 2025Jun 25
BEIJING TONG REN TANG CO., LTD.: Announcement on Obtaining a Canadian Product LicenseJul 9

All Beijing TongRenTang news releases

Follow Beijing TongRenTang into a list and get an email when it puts out news.

Follow Beijing TongRenTang